LGALS8 Mouse

Galectin-8 Mouse Recombinant
Shipped with Ice Packs
In Stock

Description

Key Biochemical Parameters

ParameterValue/DescriptionSource
Molecular Weight38.6 kDa (short isoform, confirmed by MALDI-TOF)
TagHis-Tag (recombinant protein expressed in E. coli)
Concentration0.5 mg/mL (determined by Bradford assay)
Purity>90% (SDS-PAGE validated)
ED50 (Agglutination)≤2 µg/mL (human red blood cells)

Isoform-Specific Interactions

Proteomic analysis in HEK293T cells revealed:

  • 22 shared interactors (e.g., lysosomal proteins, adhesion molecules).

  • 9 unique interactors for Gal-8S: Includes CLCN3, CLCN7, LAMP1, and LAMP2, linked to secretory vesicle function .

Osteoclast Activity

  • Bone Resorption: Gal-8S is the predominant isoform in mature osteoclasts, accounting for ~60% of total Gal-8 expression. Inhibition of Gal-8S reduces osteoclast nuclearity and bone resorption activity .

  • mTORC1 Signaling: Gal-8 regulates mTORC1, a pathway critical for osteoclast differentiation and survival .

  • Proteomics: Gal-8S interacts with lysosomal proteins (e.g., LAMP1/2), suggesting a role in vesicle secretion during bone degradation .

Immune Modulation

  • Tumor Microenvironment: High Gal-8 expression correlates with immunosuppression, promoting expansion of regulatory T cells (Tregs) and myeloid-derived suppressor cells (MDSCs) while reducing CD8+ T cell infiltration .

  • Cytokine Production: Induces IL-1β, TNF-α, IL-6, and chemokines (e.g., SDF-1, MCP-1) in immune cells, exacerbating inflammation and metastasis .

Cancer Progression

  • Metastasis: Gal-8 secreted by tumors creates a "vicious cycle," recruiting tumor cells to metastatic niches via chemoattractant secretion .

  • Clinical Relevance: Elevated LGALS8 expression in breast and colorectal cancers correlates with lymph node metastasis and poor prognosis .

Osteoclast Proteomics

Interacting ProteinFunctionIsoform Specificity
CLCN3Chloride channel, lysosomal pHGal-8S
CLCN7Lysosomal degradationGal-8S
LAMP1Lysosomal membrane proteinGal-8S
LAMP2Chaperone-mediated autophagyGal-8S

Data derived from LC-MS/MS analysis of HEK293T cells expressing Gal-8 isoforms .

Tumor Immunology

  • MDSC Expansion: Gal-8-rich tumors exhibit increased MDSC infiltration, suppressing T-cell activity .

  • Gene Expression: LGALS8 negatively correlates with CD8+ T cell abundance and immune stimulatory genes (e.g., CXCL9) in clinical samples .

Autoimmune and Inflammatory Diseases

  • Rheumatoid Arthritis: Gal-8 induces phosphatidylserine exposure on synovial fluid cells, promoting apoptosis and disease severity .

  • Experimental Autoimmune Encephalomyelitis (EAE): Gal-8 deficiency delays disease onset but exacerbates severity, highlighting its dual immunomodulatory role .

Product Specs

Introduction
LGALS8, a prostate-specific antigen, exhibits exclusive overexpression in malignant tumors, making it a valuable supplementary marker for identifying malignancies. This protein belongs to the galectin family, which plays a crucial role in mediating cell-cell and cell-matrix interactions, similar to the selectin family of C-type lectins.
Description
Recombinant LGALS8, produced in E. coli, is a single polypeptide chain consisting of 339 amino acids (residues 1-316) and possessing a molecular weight of 38kDa. This protein is engineered with a 23 amino acid His-tag fused at its N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A sterile-filtered solution, clear and colorless.
Formulation
The LGALS8 solution is supplied at a concentration of 0.5mg/ml and is formulated in 20mM Tris-HCl buffer at pH 8.0, containing 0.15M NaCl, 20% glycerol, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, it is recommended to store the product frozen at -20°C. To ensure optimal stability during long-term storage, the addition of a carrier protein (0.1% HSA or BSA) is advised. Repeated freeze-thaw cycles should be minimized.
Purity
The purity of the protein is determined to be greater than 90.0% using SDS-PAGE analysis.
Assay Conditions
1. Prepare a mixture of equal volumes of human blood and Alsever's solution (pH 7.0). Alsever's solution composition: NaCl (0.42g), Sodium citrate (0.8g), Citric acid (0.055g), and D-glucose (2.05g) dissolved in 100 ml of distilled water. 2. Centrifuge the blood-Alsever's solution mixture at 15,000 rpm for 10 minutes. Wash the resulting pellet four times with PBS. 3. Resuspend the packed cells in a 0.5mg/ml trypsin-EDTA solution to achieve a 4% red cell suspension. 4. Incubate the cell suspension for 1 hour at 37°C. Wash the cells four times with PBS. 5. Resuspend the packed cells in PBS to obtain a 4% red cell suspension. 6. Dispense 50µl of 0.5% BSA in 0.15M NaCl solution and 25µl of the 4% red cell suspension in PBS into separate wells of a U-shaped well plate. 7. Add 25µl of serially diluted galectin protein in PBS to each well of the plate (using a round-bottom 96-well plate). 8. Incubate the plate for 30 minutes at room temperature and visually assess for agglutination.
Biological Activity
The ED₅₀ (effective dose for 50% response) is approximately 2µg/ml, as determined by the protein's ability to agglutinate human red blood cells.
Synonyms
Galectin-8, Gal-8, LGALS-8, AI326142, D13Ertd524e, 1200015E08Rik.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSMLSLNNL QNIIYNPIIP YVGTITEQLK PGSLIVIRGH VPKDSERFQV DFQLGNSLKP RADVAFHFNP RFKRSSCIVC NTLTQEKWGW EEITYDMPFR KEKSFEIVFM VLKNKFQVAV NGRHVLLYAH RISPEQIDTV GIYGKVNIHS IGFRFSSDLQ
SMETSALGLT QINRENIQKP GKLQLSLPFE ARLNASMGPG RTVVIKGEVN TNARSFNVDL VAGKTRDIAL HLNPRLNVKA FVRNSFLQDA WGEEERNITC FPFSSGMYFE MIIYCDVREF KVAINGVHSL EYKHRFKDLS SIDTLSVDGD IRLLDVRSW.

Q&A

What is the expression profile of LGALS8 across different mouse brain regions?

LGALS8 shows a heterogeneous expression pattern across mouse brain regions. It demonstrates moderate expression in the molecular cell layer (MCL), accessory olfactory bulb's granular cell layer (AOB GCL), and the glomerular layer (GL) of the olfactory bulb, albeit at lower intensity compared to other galectins like LGALS9 . In the cerebellum, LGALS8 shows very low expression in the granular cell layer (GCL) with some cells showing below moderate intensity levels, while higher expression is observed in the Purkinje cell layer (PCL) . LGALS8 also exhibits moderate expression throughout the substantia nigra, though with lower cellular density compared to LGALS9 .

How does LGALS8 expression in mouse brain compare to other galectins?

LGALS8 shows a more conserved expression profile across mouse and human brains compared to other galectins. While LGALS9 has maximal spatial distribution across mouse brain with inferred predominant roles in neurogenesis, LGALS8 shows more specific localization patterns . Notable differences exist in limbic regions associated with learning, memory, and emotions, as well as in the substantia nigra associated with motor movements, where LGALS1 and LGALS8 show strikingly high expression in human versus mouse brain .

What transcription factors regulate LGALS8 expression in mouse brain?

Several transcription factors have been identified as potential regulators of LGALS8 expression in mouse brain. These include SMARCA4, SOX2, MYC, FOXP3, KLF4, and CTCF, which show co-expression with LGALS8 particularly in the molecular cell layer of the olfactory bulb . In the Purkinje cell layer of the cerebellum, MYC, ESRRB, and SOX2 are predicted to regulate LGALS8 expression and show correlation with its distinctive boundary expression . In the substantia nigra, SOX2 and POU5F1 appear to be potential regulators of LGALS8 .

How do we reconcile contradictory findings about LGALS8's role in neuronal migration and axon pathfinding?

While direct evidence for LGALS8's role in neuronal migration from the search results is limited, researchers can approach this question methodologically by:

  • Conducting time-course expression studies of LGALS8 during development

  • Performing cell-specific knockdown experiments in neural precursor cells

  • Using live-cell imaging to track migration patterns in LGALS8-deficient neurons

  • Comparing LGALS8 with LGALS3, which has established roles in neuronal migration

The expression of LGALS8 in the rostral migratory stream and olfactory bulb suggests potential involvement in neuroblast migration, similar to that reported for LGALS3 . Contradictory findings might be reconciled by examining cell-type specific effects and developmental timing of expression.

What functional domains of LGALS8 are critical for its neurological functions?

This question requires experimental approaches focusing on structure-function relationships:

  • Generate domain-specific mutations or truncations of LGALS8

  • Express these modified proteins in neuronal cultures to assess effects on neurite outgrowth, synapse formation, and neuronal survival

  • Conduct pull-down assays to identify binding partners specific to each domain

  • Perform in vivo expression of domain mutants using viral vectors to assess region-specific functions

This methodological approach can help determine whether the carbohydrate recognition domain or other structural elements of LGALS8 are essential for its neurological functions.

How does LGALS8 contribute to the functional divergence between mouse and human brain evolution?

The search results indicate that LGALS8's expression profile is most preserved between mouse and human brains compared to other galectins . To investigate its evolutionary significance:

  • Perform comparative transcriptomics of LGALS8 expression in homologous brain regions across multiple species

  • Analyze species-specific binding partners using cross-species proteomics

  • Examine the conservation of regulatory elements in LGALS8 promoter regions

  • Use CRISPR to humanize mouse LGALS8 regulatory regions and assess phenotypic changes

This approach can reveal whether LGALS8 contributes to conserved neurological functions or species-specific adaptations.

What are the optimal methods for detecting LGALS8 protein expression in mouse brain samples?

Based on the available information, researchers should consider multiple detection methods:

TechniqueApplicationSensitivityAdvantagesLimitations
ELISAQuantitative measurement0.1 ng/ml High sensitivity, quantitative resultsNo spatial information
ImmunohistochemistrySpatial distributionModeratePreserves anatomical contextAntibody specificity concerns
In situ hybridizationmRNA localizationHighDirect transcript detectionDoesn't confirm protein expression
Western blottingProtein expressionModerateSize verificationLoss of spatial information

For ELISA-based detection, the Abbexa LGALS8 ELISA kit offers a detection range of 0.156-10 ng/ml with a sensitivity of 0.1 ng/ml . This sandwich ELISA method is suitable for tissue homogenates, cell lysates, and other biological fluids .

How should researchers design experiments to study LGALS8 function in specific brain regions?

A comprehensive experimental design should include:

  • Region-specific conditional knockout or knockdown approaches

    • Cre-loxP system targeting specific neuronal populations

    • Viral vector delivery of shRNA to specific brain regions

  • Functional assessments based on regional expression patterns

    • For substantia nigra studies: motor coordination tests

    • For olfactory bulb studies: olfactory discrimination tasks

    • For cerebellar studies: motor learning paradigms

  • Molecular interaction studies

    • Region-specific proteomics to identify binding partners

    • Co-immunoprecipitation experiments from specific brain regions

  • Control experiments

    • Use of appropriate control regions where LGALS8 expression is minimal

    • Validation with multiple antibodies or detection methods

What are the methodological considerations for studying LGALS8 in neurodevelopmental processes?

Based on LGALS8's expression patterns, researchers should consider:

  • Temporal analysis

    • Embryonic, postnatal, and adult expression profiling

    • Time-course studies during critical developmental periods

  • Cell culture models

    • Primary neuronal cultures from specific brain regions

    • Neural stem cell differentiation assays

  • Developmental perturbation studies

    • In utero electroporation of LGALS8 constructs

    • Early postnatal viral injections for temporal manipulation

  • Lineage tracing experiments

    • Fate mapping of LGALS8-expressing progenitors

    • Analysis of progeny distribution and differentiation

How should researchers normalize LGALS8 expression data across different brain regions?

Normalization strategies should account for regional cellular heterogeneity:

  • Use multiple reference genes that show stable expression across brain regions

  • Consider cell type-specific normalization factors based on regional cellular composition

  • Employ absolute quantification methods when comparing highly divergent regions

  • Report both absolute and relative expression values when possible

For LGALS8 specifically, researchers should be aware that its expression varies significantly across brain regions and cell types, with particularly notable expression in the Purkinje cell layer of the cerebellum and moderate expression in the substantia nigra .

What statistical approaches are most appropriate for analyzing LGALS8 co-expression with transcription factors?

Based on the galectin-TF co-expression analyses reported in the literature :

  • Correlation analyses

    • Pearson or Spearman correlation coefficients for expression intensity correlations

    • Weighted gene co-expression network analysis (WGCNA) for identifying modules

  • Spatial statistics

    • Moran's I or Geary's C for spatial autocorrelation analysis

    • Ripley's K function for point pattern analysis of co-expressing cells

  • Multivariate approaches

    • Principal component analysis to identify main sources of variation

    • Multiple regression models incorporating spatial coordinates

  • Validation strategies

    • Bootstrap resampling to assess stability of co-expression relationships

    • Cross-validation across multiple brain samples

How can researchers integrate LGALS8 expression data with functional analyses?

Integrative analytical approaches should include:

  • Gene ontology enrichment analysis of co-expressed genes

  • Pathway analysis incorporating LGALS8 and its binding partners

  • Integration with behavioral phenotyping data from LGALS8 mutant mice

  • Correlation of region-specific expression levels with region-specific functions

The research indicates that LGALS8 shows co-expression with transcription factors like SOX2 and FOXP3, suggesting potential functional relevance in processes regulated by these factors .

How conserved is LGALS8 expression and function between mouse and human brain?

The available data suggests that LGALS8 shows the most preserved expression pattern across mouse and human brain compared to other galectins . Researchers investigating evolutionary conservation should:

  • Compare sequence homology of mouse and human LGALS8

  • Analyze conservation of protein domains, particularly carbohydrate recognition domains

  • Examine expression patterns in homologous brain structures

  • Identify species-specific binding partners

Notable differences exist in limbic regions and substantia nigra, where LGALS8 shows higher expression in human compared to mouse brain . This suggests potential species-specific functions in these regions that may relate to higher cognitive functions and motor control.

What experimental approaches can identify conserved vs. divergent functions of LGALS8 across species?

Researchers can employ these methodological approaches:

  • Cross-species binding assays

    • Compare glycan binding profiles between mouse and human LGALS8

    • Identify species-specific binding partners

  • Humanized mouse models

    • Replace mouse LGALS8 with human variant

    • Assess phenotypic consequences

  • Comparative transcriptomics

    • Single-cell RNA sequencing of homologous regions across species

    • Analysis of co-expression networks

  • Evolutionary rate analysis

    • Calculate dN/dS ratios for detection of selection signatures

    • Identify rapidly evolving domains

How does LGALS8 relate functionally to other galectin family members in mouse brain?

The search results indicate complex relationships between LGALS8 and other galectins in mouse brain . To investigate these relationships, researchers should:

  • Perform comprehensive co-expression analyses of all galectin family members

  • Conduct functional compensation studies using multiple galectin knockouts

  • Identify unique vs. overlapping binding partners between galectins

  • Analyze evolutionary patterns of galectin gene duplication and specialization

LGALS8 shows unique expression patterns in the Purkinje cell layer compared to other galectins, suggesting specialized functions in cerebellar circuits . Its expression in the substantia nigra, alongside LGALS9 but with different cellular density, indicates potential complementary roles in motor control .

Product Science Overview

Introduction

Galectin-8, also known as Gal-8, is a member of the galectin family, which are beta-galactoside-binding animal lectins with conserved carbohydrate recognition domains (CRDs). Galectin-8 is a tandem-repeat type galectin, containing two CRDs connected by a linker peptide . This protein is expressed in various tissues and has been implicated in numerous biological processes, including cell adhesion, migration, and angiogenesis .

Structure and Expression

Galectin-8 was initially cloned from a rat liver cDNA library and is composed of 316 amino acids, with a molecular weight of approximately 35 kDa . The N- and C-terminal domains of Galectin-8 share 35% homology and contain sequence motifs conserved among most CRDs of galectins . The mouse recombinant version of Galectin-8 is expressed in Escherichia coli and has a purity of over 90%, making it suitable for various applications such as SDS-PAGE and mass spectrometry .

Biological Functions

Galectin-8 plays a crucial role in various biological processes. It is involved in the regulation of vascular and lymphatic angiogenesis, which is the formation of new blood and lymphatic vessels . This protein has been shown to control capillary-tube formation, endothelial cell (EC) migration, and in vivo angiogenesis . Additionally, Galectin-8 interacts with specific ligands such as podoplanin in lymphatic vessels and CD166 (ALCAM) in vascular ECs .

Role in Disease and Therapeutic Potential

Galectin-8 has significant implications in tumor biology. It is expressed in both normal and tumor-associated blood vessels, as well as in lymphatic endothelial cells . The protein’s role in tumor angiogenesis and metastasis is of particular interest, as modulating Galectin-8-glycan interactions could potentially block lymphatic-vascular connections vital for metastasis . Furthermore, Galectin-8 has been shown to restrict the proliferation of infecting pathogens by targeting them for autophagy, making it a potential therapeutic target for infectious diseases .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.